Rolle des Mikrobioms und die gastrointestinale Barrierefunktion – klinische Implikationen

• Literatur

• 1 Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134: 577-594
• 2 Hollister EB, Riehle K, Luna RA et al. Structure and function of the healthy pre-adolescent pediatric gut microbiome. Microbiome 2015; 3: 36
• 3 Eckburg PB, Bik EM, Bernstein CN et al. Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-1638
• 4 Frank DN, St Amand AL, Feldman RA et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007; 104: 13780-13785
• 5 Qin J, Li R, Raes J et al. A human gut microbial gene catalog established by metagenomic sequencing. Nature 2010; 464: 59-65
• 6 Arumugam M, Raes J, Pelletier E et al. Enterotypes of the human gut microbiome. Nature 2011; 473: 174-80
• 7 Hildebrand F, Nguyen TL, Brinkman B et al. Inflammation-associated enterotypes, host genotype, cage and inter-individual effects drive gut microbiota variation in common laboratory mice. Genome Biol 2013; 14: R4
• 8 Dixon J, Strugala V, Griffin SM et al. Esophageal mucin: an adherent mucus gel barrier is absent in the normal esophagus but present in columnar-lined Barrett‘s esophagus. Am J Gastroenterol 2001; 96: 2575-2583
• 9 Johansson ME, Larsson JM, Hansson GC. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci USA 2011; 108: 4659-4665
• 10 Wehkamp J, Schmid M, Stange EF. Defensins and other antimicrobial peptides in inflammatory bowel disease. Curr Opin Gastroenterol 2007; 23: 370-378
• 11 Schroeder BO, Wu Z, Nuding S et al. Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1. Nature 2011; 469: 419-423
• 12 Braun A, Treede I, Gotthardt D et al. Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: a clue to pathogenesis. Inflamm Bowel Dis 2009; 15: 1705-1720
• 13 Hosaka Y, Koslowski M, Nuding S et al. Antimicrobial host defense in the upper gastrointestinaltract. Eur J Gastroenterol Hepatol 2008; 20: 1151-1158
• 14 Celli JP, Turner BS, Afdhal NH et al. Helicobacter pylori moves through mucus by reducing mucin viscoelasticity. Proc Natl Acad Sci USA 2009; 106: 14321-14326
• 15 Cullen TW, Giles DK, Wolf LN et al. Helicobacter pylori versus the host: remodeling of the bacterial outer membrane is required for survival in the gastric mucosa. PLoS Pathog 2011; 7: e1002454
• 16 Nuding S, Gersemann M, Hosaka Y et al. Gastric antimicrobial peptides fail to eradicate Helicobacter pylori infection due to selective induction and resistance. PLoS One 2013; 8: e73867
• 17 Wada A, Mori N, Oishi K et al. Induction of humanbeta-defensin-2 mRNA expression by Helicobacter pylori in human gastric cell line MKN45 cells on cag pathogenicity island. Z Biochem Biophys Res Commun 1999; 263: 770-774
• 18 Maixner F, Krause-Kyora B, Turaev D et al. The 5300-year-old Helicobacter pylori genome of the Iceman. Science 2016; 351: 162-165
• 19 Nigro G, Rossi R, Commere PH et al. The cytosolic bacterial peptidoglycan sensor Nod2 affords stem cell protection and links microbes to gut epithelial regeneration. Cell Host Microbe 2014; 15: 792-798
• 20 Wehkamp J, Harder J, Weichenthal M et al. NOD2 (CARD15) mutations in Crohn‘s disease are associated with diminished mucosal alpha-defensin expression. Gut 2004; 53: 1658-1664
• 21 Wehkamp J, Harder J, Wehkamp K et al. NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun 2004; 72: 5750-5758
• 22 Raqib R, Sarker P, Bergman P et al. Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc Natl Acad Sci USA 2006; 103: 9178-9183
• 23 Rawls JF, Mahowald MA, Ley RE et al. Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell 2006; 127: 423-433
• 24 Wenzel UA, Magnusson MK, Rydström A et al. Spontaneous colitis in Muc2-deficient mice reflects clinical and cellular features of active ulcerative colitis. PLoS One 2014; 9: e100217
• 25 Salzman NH, Ghosh D, Huttner KM et al. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 2003; 422: 522-526
• 26 Swidsinski A, Ladhoff A, Pernthaler A et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002; 122: 44-54
• 27 Ostaff MJ, Stange EF, Wehkamp J. Antimicrobial peptides and gut microbiota in homeostasis and pathology. EMBO Mol Med 2013; 5: 1465-1483
• 28 Wehkamp J, Götz M, Herrlinger K et al. Chronisch entzündliche Darmerkrankungen. Dtsch Arztebl Int 2016; 113: 72-82
• 29 Johansson ME, Sjövall H, Hansson GC. The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol 2013; 10: 352-361